[go: up one dir, main page]

WO2005107364A3 - Polynucleotide, polypeptides, and diagnostic methods - Google Patents

Polynucleotide, polypeptides, and diagnostic methods Download PDF

Info

Publication number
WO2005107364A3
WO2005107364A3 PCT/IB2005/002407 IB2005002407W WO2005107364A3 WO 2005107364 A3 WO2005107364 A3 WO 2005107364A3 IB 2005002407 W IB2005002407 W IB 2005002407W WO 2005107364 A3 WO2005107364 A3 WO 2005107364A3
Authority
WO
WIPO (PCT)
Prior art keywords
polynucleotide
polypeptides
diagnostic methods
methods
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2005/002407
Other languages
French (fr)
Other versions
WO2005107364A2 (en
WO2005107364A9 (en
Inventor
Amir Toporik
Sarah Pollock
Zurit Levine
Michal Ayalon-Soffer
Gad S Cojocaru
Alexander Diber
Amit Novik
Dvir Dahary
Pinchas Akiva
Rotem Sorek
Ronen Shemesh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Compugen USA Inc
Original Assignee
Compugen USA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Compugen USA Inc filed Critical Compugen USA Inc
Priority to EP05767217A priority Critical patent/EP1735342A2/en
Priority claimed from US11/043,806 external-priority patent/US7368548B2/en
Publication of WO2005107364A2 publication Critical patent/WO2005107364A2/en
Publication of WO2005107364A9 publication Critical patent/WO2005107364A9/en
Anticipated expiration legal-status Critical
Publication of WO2005107364A3 publication Critical patent/WO2005107364A3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Novel splice variants, amino acid sequences thereof, and methods of using the same.
PCT/IB2005/002407 2004-01-27 2005-01-27 Polynucleotide, polypeptides, and diagnostic methods Ceased WO2005107364A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP05767217A EP1735342A2 (en) 2004-01-27 2005-01-27 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis

Applications Claiming Priority (50)

Application Number Priority Date Filing Date Title
US53912904P 2004-01-27 2004-01-27
US53912804P 2004-01-27 2004-01-27
US60/539,128 2004-01-27
US60/539,129 2004-01-27
US62100404P 2004-10-22 2004-10-22
US62087404P 2004-10-22 2004-10-22
US60/620,874 2004-10-22
US60/621,004 2004-10-22
US62107204P 2004-10-25 2004-10-25
US62105304P 2004-10-25 2004-10-25
US60/621,053 2004-10-25
US60/621,072 2004-10-25
US62166304P 2004-10-26 2004-10-26
US60/621,663 2004-10-26
US62232004P 2004-10-27 2004-10-27
US62201604P 2004-10-27 2004-10-27
US62201704P 2004-10-27 2004-10-27
US60/622,016 2004-10-27
US60/622,320 2004-10-27
US60/622,017 2004-10-27
US62811204P 2004-11-17 2004-11-17
US62823104P 2004-11-17 2004-11-17
US62825104P 2004-11-17 2004-11-17
US62813304P 2004-11-17 2004-11-17
US62817904P 2004-11-17 2004-11-17
US62814404P 2004-11-17 2004-11-17
US62810104P 2004-11-17 2004-11-17
US62814504P 2004-11-17 2004-11-17
US62819004P 2004-11-17 2004-11-17
US62815604P 2004-11-17 2004-11-17
US62813404P 2004-11-17 2004-11-17
US62816504P 2004-11-17 2004-11-17
US60/628,144 2004-11-17
US60/628,101 2004-11-17
US60/628,190 2004-11-17
US60/628,145 2004-11-17
US60/628,133 2004-11-17
US60/628,251 2004-11-17
US60/628,112 2004-11-17
US60/628,165 2004-11-17
US60/628,156 2004-11-17
US60/628,231 2004-11-17
US60/628,134 2004-11-17
US60/628,179 2004-11-17
US63055904P 2004-11-26 2004-11-26
US60/630,559 2004-11-26
US63407504P 2004-12-08 2004-12-08
US60/634,075 2004-12-08
US11/043,806 2005-01-27
US11/043,806 US7368548B2 (en) 2004-01-27 2005-01-27 Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer

Publications (3)

Publication Number Publication Date
WO2005107364A2 WO2005107364A2 (en) 2005-11-17
WO2005107364A9 WO2005107364A9 (en) 2006-05-11
WO2005107364A3 true WO2005107364A3 (en) 2009-04-16

Family

ID=35335669

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/002407 Ceased WO2005107364A2 (en) 2004-01-27 2005-01-27 Polynucleotide, polypeptides, and diagnostic methods

Country Status (2)

Country Link
EP (1) EP1735342A2 (en)
WO (1) WO2005107364A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20075466A0 (en) * 2007-06-19 2007-06-19 Chempath Oy Transmembrane acid phosphatase in the prostate
SMT202400136T1 (en) 2008-12-09 2024-05-14 Hoffmann La Roche Anti-pd-l1 antibodies and their use to enhance t-cell function

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999014340A1 (en) * 1997-09-19 1999-03-25 Incyte Pharmaceuticals, Inc. Human prl-1 phosphatase

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999014340A1 (en) * 1997-09-19 1999-03-25 Incyte Pharmaceuticals, Inc. Human prl-1 phosphatase

Also Published As

Publication number Publication date
WO2005107364A2 (en) 2005-11-17
WO2005107364A9 (en) 2006-05-11
EP1735342A2 (en) 2006-12-27

Similar Documents

Publication Publication Date Title
WO2006131928A3 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
WO2005084116A3 (en) Calcium channel variants
WO2005014850A3 (en) Systems and methods for analyzing nucleic acid sequences
WO2006009901A3 (en) Novel antigen-binding polypeptides and their uses
WO2007044026A3 (en) Compositions comprising modified collagen and uses therefore
WO2006017538A3 (en) Hk1-binding proteins
WO2004080148A3 (en) Novel nucleic acids and polypeptides
WO2008143668A3 (en) Indoleamine-2, 3-dioxygenase-2
WO2004064595A3 (en) Multivalent constructs for therapeutic and diagnostic applications
WO2006127757A3 (en) Interferon-igg fusion
WO2006066024A3 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
WO2007039903A3 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
WO2004087874A3 (en) Novel nucleic acids and polypeptides
IL223077A0 (en) Novel as160-like protein, test systems, methods and uses involving it for the identification of diabetes type 2 therapeutics
WO2010051056A3 (en) ANTI-FcεRI POLYPEPTIDES AND THEIR USES
WO2005108428A3 (en) Cd40 splice variants and their uses
EP1889907A4 (en) Novel amino group transferase, gene encoding the same and method of using the same
WO2006135793A3 (en) Protein engineering with analogous contact environments
WO2005049806A3 (en) Novel nucleic acids and polypeptides
WO2006054297A3 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
WO2005000876A3 (en) Ring finger family proteins and uses related thereto
AP2006003544A0 (en) Amino acids with affinity for the alpha2delta-protein.
WO2005107364A3 (en) Polynucleotide, polypeptides, and diagnostic methods
WO2003055980A3 (en) Il-17 like molecules and uses thereof
WO2003091447A3 (en) D1-1 nucleic acids, polypeptides and related methods

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1429-1436, CLAIMS, REPLACED BY CORRECT PAGES 1429-1436

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWE Wipo information: entry into national phase

Ref document number: 2005767217

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 2005767217

Country of ref document: EP